EU Customs seize 36 million fake goods

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EU Customs seize 36 million fake goods

The number of fakes seized by Customs officials in Europe fell last year for the second year running

The authorities detained nearly 36 million fake goods at EU borders in 2013. That was down from almost 40 million in 2012 and a steep drop from the 178 million articles seized in 2008.

China remained the number one country of provenance for suspected IP-infringing goods sent to the EU. Clothing came top of the list for fake products, accounting for 12% of the overall amount, followed by other goods (11%), medicines (10%), cigarettes (9%), packaging materials (9%) and toys (8%).

More detentions than ever are being made following requests from IP owners. In 2007 Customs received just over 10,000 applications for action. Last year that number had more than doubled to 26,800.

But ex officio actions have fallen as a percentage of total actions by Customs. In 2009 they accounted for almost 10% of Customs’ actions but by last year that figure had fallen to just over 3%.

Statistics revealed in a report from the European Commission show that counterfeiters and their customers are increasingly turning to mail and courier services for delivery of their products.

Cases related to postal and courier traffic accounted for 72% of all detentions. Packages were largely filled with gods such as sport shoes, bags and wallets, clothing, sunglasses and watches. In terms of number of articles detained in postal traffic, medicines remained for the fourth consecutive year the top category with 19%.

more from across site and SHARED ros bottom lb

More from across our site

Examiner statistics could help patent prosecution practitioners tailor strategies, turning an area of high variability into a potential competitive advantage
The England and Wales High Court’s ruling in Accord v Novartis may not rewrite the law on plausibility, but it does signal a pragmatic approach that could provide greater certainty for life sciences innovators
Firms with established sports relationships and specialised expertise are well positioned to capture the market’s expanded pool of IP work
Gunjan Paharia discusses developing RIA, an AI platform built to draw on decades of institutional knowledge, support junior lawyers, and reshape how legal teams work
A strong Canadian business helped lift profits, but the IP service group's latest results underline the pressure facing its operations in Australia, New Zealand and parts of Asia
Wins in court have been key to the six-year-old firm’s growth, as one of its founders explains
The firm’s co-CEO discusses patent litigation, collaboration with overseas colleagues and the next generation of leaders
Two recent decisions demonstrate the courts’ creativity in cutting-edge IP disputes that tested their jurisdictional powers
Aditi Verma Thakur, managing partner at Aishani Partners, discusses 5 am wake-ups, working with high-performing professionals and staying calm under pressure
After more than three decades at Wilson Sonsini, Ian Edvalson explains why he moved to expand his life sciences transactional practice
Gift this article